Dietary tartary buckwheat intake attenuates insulin resistance and improves lipid profiles in patients with type 2 diabetes: a randomized controlled trial | Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds | Alps Pharmaceutical Ind. Co.,Ltd.

Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Dietary tartary buckwheat intake attenuates insulin resistance and improves lipid profiles in patients with type 2 diabetes: a randomized controlled trial

Authors:: Ju Qiu; Yanping Liu; Yanfen Yue; Yuchang Qin; Zaigui Li

Reference:: Nutrition Research; 2016; 36; 1392-1401

DOI:: 10.1016/j.nutres.2016.11.007

See Abstract

Key Words:: Clinical study; randomization; placebo controlled; open-label; parallel-group; diabetes mellitus, type II; tartary buckwheat; insulin; insulin resistance; cholesterol

Back to index